Investment Summary

HBM Partners, Vivo Capital and Idinvest Partners Invest In IO Biotech

On January 13, 2021, private equity firm HBM Partners, growth capital firm Vivo Capital and private equity firm Idinvest Partners invested in life science company IO Biotech

Investment Highlights
  • This is HBM Partners’ 44th, Vivo Capital’s 13th and Idinvest Partners’ 10th transaction in the Life Science sector.
  • This is HBM Partners’ 1st, Vivo Capital’s 1st and Idinvest Partners’ 2nd transaction in Denmark.
Investment Fate
  • IO Biotech went public in 2021.

Investment Summary

Date 2021-01-13
Target IO Biotech
Sector Life Science
Investor(s) HBM Partners
Vivo Capital
Idinvest Partners
Deal Type Venture

Target

IO Biotech

Copenhagen, Denmark
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for the treatment of cancer. IO Biotech's pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules. IO Biotech was founded in 2014 and is based in Copenhagen, Denmark.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 3

Investor

HBM Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 2.1B USD
Size Large
Type Sector Focused
DESCRIPTION

HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.


DEAL STATS #
Overall 51 of 65
Sector: Life Science M&A 44 of 56
Type: Venture M&A Deals 41 of 52
Country: Denmark M&A 1 of 1
Year: 2021 M&A 4 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-11 Genalyte

San Diego, California, United States

Genalyte is a healthcare diagnostics and analytics company that improves patient outcomes and lowers cost with real-time results for physicians and patients. Genalyte was founded in 2007 and is based in San Diego, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-15 Farmalisto

Bogota, Colombia

Farmalisto is a technology healthcare platform in Latin America that connects providers and users of the healthcare system to enhance value creation and delivery to end customers. The company has operations in Mexico, Colombia, and Chile. Farmalisto is expanding its services to become a partner of choice for pharmaceutical companies in logistics, marketing and disease management. Farmalisto was founded in 2013 and is based in Bogota, Colombia.

Buy -
Investor

Vivo Capital

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1996
PE ASSETS 6.4B USD
Size Mega
Type Sector Focused
DESCRIPTION

Vivo Capital is a healthcare investment firm focused on opportunities throughout the US and China. Specific areas of interest include biopharmaceuticals, specialty pharmaceuticals, and medical devices. The Firm looks to identify and work with companies at the development and commercial stage products in the US and at the revenue stage in China. Vivo Capital was established in 1997 and is headquartered in Palo Alto, California.


DEAL STATS #
Overall 18 of 18
Sector: Life Science M&A 13 of 13
Type: Venture M&A Deals 13 of 13
Country: Denmark M&A 1 of 1
Year: 2021 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-05 Seran

Bend, Oregon, United States

Seran is a contract development and manufacturing organization providing a comprehensive suite of development, analytical and clinical manufacturing services to pharmaceutical and biotechnology companies. Seran was founded in 2016 and is based in Bend, Oregon.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-01 Surgical Specialties

Westwood, Massachusetts, United States

Surgical Specialties is a medical device company that develops and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions, and acute injury.

Sell -
Investor

Idinvest Partners

Paris, France

Category Private Equity Firm
Founded 1997
PE ASSETS 7.6B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Idinvest Partners is a European investment firm focused on investing in small to mid-sized companies at various stages of development. Idinvest segments its investment activity into three groups. These include venture and growth capital, private debt, and dedicated portfolios/funds. Idinvest's venture and growth capital group looks to invest directly in early stage companies with high growth potential. Idinvest's private debt group seeks to provide senior or subordinated debt to small and mid-sized companies pursuing growth objectives. Idinvest's dedicated portfolio/funds group looks to invest in private equity funds, acquire secondary fund positions, and directly co-invest alongside other private equity firms in established companies. Idinvest Partners was formed in 1997 and is based in Paris.


DEAL STATS #
Overall 78 of 78
Sector: Life Science M&A 10 of 10
Type: Venture M&A Deals 30 of 30
Country: Denmark M&A 2 of 2
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-25 Bimedia est une marque de Buralog SAS

La Roche-sur-Yon, France

Bimedia is a provider of commercial hardware and business software solutions for local retailers. Bimedia was formed in 2002 and is based in La Roche-sur-Yon, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-20 21Buttons

Barcelona, Spain

21Buttons is a social media fashion network. 21Buttons was founded in 2015 and is based in Barcelona, Spain.

Sell -